Literature DB >> 1586186

Risk factors for necrotising enterocolitis: the influence of gestational age.

P J Beeby1, H Jeffery.   

Abstract

Over a 7 year study period, 82 infants were identified who had necrotising enterocolitis (NEC). A case-control study of the 74 preterm infants was performed to determine those factors which contributed to the development of NEC. The 35 infants with NEC and gestation between 30-36 weeks, when compared with control infants matched for gestational age, had significantly lower birthweight centiles, cord pH, and 1 minute Apgar scores. By contrast, there were no significant differences between the 39 infants with NEC and controls in the 25-29 week group, except that fewer babies with NEC had received breast milk. The eight term babies all appeared to have an obvious predisposing event. We thus propose a model in which susceptibility to NEC is dependent on gestational age. In the 25-29 week range all babies are at risk on the basis of extreme prematurity. In the 30-36 week range asphyxiated and growth retarded babies are at increased risk, while at term a major predisposing event appears to be required.

Entities:  

Mesh:

Year:  1992        PMID: 1586186      PMCID: PMC1590486          DOI: 10.1136/adc.67.4_spec_no.432

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  25 in total

1.  Risk factors for late-onset necrotizing enterocolitis.

Authors:  P Vinocur; M J Stine
Journal:  Indiana Med       Date:  1990-07

2.  Absent or reversed end diastolic flow velocity in the umbilical artery and necrotising enterocolitis.

Authors:  G Malcolm; D Ellwood; K Devonald; R Beilby; D Henderson-Smart
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

3.  Idiopathic intestinal perforations in the newborn: an increasingly common entity.

Authors:  G Weinberg; S Kleinhaus; S J Boley
Journal:  J Pediatr Surg       Date:  1989-10       Impact factor: 2.545

4.  Factors associated with age of onset of necrotizing enterocolitis.

Authors:  R F Covert; J Neu; M J Elliott; J L Rea; P A Gimotty
Journal:  Am J Perinatol       Date:  1989-10       Impact factor: 1.862

5.  Perinatal events and necrotizing enterocolitis in premature infants.

Authors:  W P Kanto; R Wilson; G L Breart; S Zierler; D M Purohit; G J Peckham; R C Ellison
Journal:  Am J Dis Child       Date:  1987-02

6.  A case control study of necrotizing enterocolitis occurring over 8 years in a neonatal intensive care unit.

Authors:  M De Curtis; C Paone; G Vetrano; G Romano; R Paludetto; F Ciccimarra
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

7.  Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding.

Authors:  M M Eibl; H M Wolf; H Fürnkranz; A Rosenkranz
Journal:  N Engl J Med       Date:  1988-07-07       Impact factor: 91.245

8.  Necrotizing enterocolitis in term infants.

Authors:  R A Polin; P F Pollack; B Barlow; H J Wigger; T L Slovis; T V Santulli; W C Heird
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

9.  Doppler studies in the growth retarded fetus and prediction of neonatal necrotising enterocolitis, haemorrhage, and neonatal morbidity.

Authors:  G A Hackett; S Campbell; H Gamsu; T Cohen-Overbeek; J M Pearce
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-03

10.  Birthweight-specific risk factors for necrotising enterocolitis.

Authors:  S R Palmer; S J Thomas; R W Cooke; D C Low; W J Fysh; J F Murphy; G M Gandy; H R Gamsu
Journal:  J Epidemiol Community Health       Date:  1987-09       Impact factor: 3.710

View more
  35 in total

Review 1.  Hypoglycaemia of the newborn: a review.

Authors:  A F Williams
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  Epidemiology and outcome of "early-onset" vs "late-onset" necrotizing enterocolitis.

Authors:  Hakam Yaseen; Khalid Kamaledin; Khalid Al Umran; Abdulatif Al Arfaj; Maha Darwich; Bassam Awary
Journal:  Indian J Pediatr       Date:  2002-06       Impact factor: 1.967

3.  T-cell-mediated mucosal immunity is attenuated in experimental necrotizing enterocolitis.

Authors:  A Anttila; H Kauppinen; A Koivusalo; P Heikkila; E Savilahti; R Rintala
Journal:  Pediatr Surg Int       Date:  2003-05-23       Impact factor: 1.827

Review 4.  Feeding growth restricted preterm infants with abnormal antenatal Doppler results.

Authors:  J Dorling; S Kempley; A Leaf
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-09       Impact factor: 5.747

Review 5.  Necrotizing enterocolitis: It's not all in the gut.

Authors:  Alissa L Meister; Kim K Doheny; R Alberto Travagli
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-06

6.  Low mortality in necrotizing enterocolitis associated with coagulase-negative Staphylococcus infection.

Authors:  Miguel Sáenz de Pipaón Marcos; Juan Rodríguez Delgado; Miriam Martínez Biarge; Jesús Pérez Rodríguez; Grevelyn Sosa Rotundo; Juan A Tovar Larrucea; José Quero Jiménez
Journal:  Pediatr Surg Int       Date:  2008-05-06       Impact factor: 1.827

7.  Congenital heart disease in low-birth-weight infants: effects of small for gestational age (SGA) status and maturity on postoperative outcomes.

Authors:  Daniel Wei; Colleen Azen; Shazia Bhombal; Laura Hastings; Lisa Paquette
Journal:  Pediatr Cardiol       Date:  2014-07-06       Impact factor: 1.655

Review 8.  Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.

Authors:  Sam J Oddie; Lauren Young; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2017-08-30

9.  The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis.

Authors:  A K Ewer; W Al-Salti; A M Coney; J M Marshall; P Ramani; I W Booth
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  Changes in hepatic cell junctions structure during experimental necrotizing enterocolitis: effect of EGF treatment.

Authors:  Ludmila Khailova; Katerina Dvorak; Kelly M Arganbright; Catherine S Williams; Melissa D Halpern; Bohuslav Dvorak
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.